China, Aug. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Screening and clinical application of biomarkers for immunotherapy efficacy in hepatocellular carcinoma'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130655
Registration Time: 2026/08/23
Type: Observational study
Primary Sponsor: The First Affiliated Hospital of Guilin Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336093
Published by HT Digital Content Services with permission from Health Daily Digest....